Shares of Monster Beverage Corporation (NASDAQ:MNST) opened at $56.26, and ended 0.83% higher at $56.83. Nearly 1.35 million shares were traded by the close, lower than its average daily volume of 1.84 million shares.Monster Beverage Corporation (MNST) Analyst Opinion
Monster Beverage Corporation has a consensus outperform rating from 17 Wall Street analysts, and the number of shares currently sold short amount to at least 1.79% of shares outstanding. The stock spiked 3.01% last month and is up 28.17 this year. Wall Street is only getting more bullish on the stock, with 14 of analysts who cover MNST having a buy-equivalent rating. Analysts have placed a $58.24 price target on Monster Beverage Corporation, suggesting a 2.48% gain from recent close. It’s currently trading about -0.73% below its 52-week high.
Monster Beverage Corporation (MNST) failed to surprise the stock market in its last reported earnings when it earned $0.39 a piece versus the consensus-estimated $0.4. Its revenue totaled $904.41 million up 21.86% from the previous quarter.Monster Beverage Corporation (NASDAQ:MNST) Intraday View
This stock (MNST) is ahead of its 52-week low with 39.84%. Its last month’s stock price volatility remained 1.06% which for the week stands at 1.15%. The share price has moved forward from its 20 days moving average, trading at a distance of 2.09% and stays 2.23% away from its 50 days moving average. Over the last five days, shares have managed 0.55% gains and now is up 14.68% since hitting its 200-day moving average of $51.82. Monster Beverage Corporation (MNST) has made its way to a 12-month gain of 13.57%.
Turning to CorMedix, Inc. (NYSE:CRMD), its shares were trading at $0.57 a retreat of $-0.01, on the trading floor. The stock, after opening at $0.58, touched a high of $0.6 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. CorMedix, Inc. has 0 buy ratings, 1 holds and 0 sells even after the stock tumbled -77.02% from its high of $ 2.48 to a $34.26 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2.5 to 2.5 during a month. Analysts set a 12-month price target of $4 a share. The target implies a 601.75% spike from where the shares are currently trading. Also, the current price highlights a discount of 601.75% to analysts’ high consensus price target.CorMedix, Inc. (NYSE:CRMD) Intraday Trading
The counter witnessed a trading volume of 1.12 million shares versus an average volume of 1.32 million shares during last trading session. Its last month’s stock price volatility remained 8.47% which for the week approaches 12.16%. The lowest price the stock reached in the last trading day was $0.55 and compares with the $0.32 52-week low. The stock recovered 77.02% since its low point and has performed -62.75% year-to-date.